2003
Multiple Sclerosis and Epstein-Barr Virus
Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A. Multiple Sclerosis and Epstein-Barr Virus. JAMA 2003, 289: 1533-1536. PMID: 12672770, DOI: 10.1001/jama.289.12.1533.Peer-Reviewed Original ResearchConceptsViral capsid antigenEpstein-Barr virusRisk of MSMultiple sclerosisRelative riskDevelopment of MSEBV viral capsid antigenOnset of MSCase-control studyDefense Serum RepositoryBlood sample collectionUS military personnelRace/ethnicityEBNA complexEBV antibodiesEBV infectionCytomegalovirus antibodiesSerum levelsCapsid antigenEarly antigenMS onsetAntibody titersIgG antibodiesPermanent disabilitySerum Repository
2001
Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis: A Prospective Study
Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernán MA, Olek MJ, Hankinson SE, Hunter DJ. Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis: A Prospective Study. JAMA 2001, 286: 3083-3088. PMID: 11754673, DOI: 10.1001/jama.286.24.3083.Peer-Reviewed Original ResearchConceptsEpstein-Barr virusViral capsid antigenCases of MSGeometric mean titersHealth Study IIMultiple sclerosisSerum antibody titersRelative riskAntibody titersDisease onsetEBNA-2Health StudyRole of EBVNurses' Health Study IIEBV viral capsid antigenEpstein-Barr virus antibodiesEtiology of MSOccurrence of MSHealthy age-matched controlsNurses' Health StudyCorresponding relative risksCase-control studyAge-matched controlsCMV antigensEBV antibodies